These three brain tumor researchers are relentless in unraveling the mysteries of this formidable disease, cell by cell, experiment after experiment.
They are investigating drug compounds and proteins to stem the progression of aggressive tumors to pushing the boundaries of research into new approaches. Morgan Schrock, DVM, PhD, Trang Nguyen, PhD and Stephanie Seidlits, PhD are part of the community of scientists making important discoveries that may one day foster breakthroughs for brain tumors.
As recipients of the ABTA’s prestigious research grants, they received funding to support research that may have the potential to change the lives of people impacted by a brain tumor diagnosis.
Read more about the progress of their innovative brain tumor research since they received an ABTA grant and how it has impacted their careers.
Jean Arzbaecher, RN, MS
Jean Arzbaecher is an advanced practice nurse working as a clinical nurse specialist in neuro-oncology at the University of Illinois Brain Tumor Center. Jean has spent her entire career in
Join Us to Raise Awareness and Funds for GBM Research
Double your impact toward our $50,000 goal to accelerate high-risk, high-reward research during GBM Awareness Day (7/17).
Uncovering New Approaches to Accelerate GBM Treatment
In recognition of GBM Awareness Day, discover two emerging researchers taking novel approaches to overcome obstacles in treating glioblastoma.
Beyond Brain Tumor Breakthroughs
Since its inception, the ABTA Research program has awarded almost $33 million dollars to scientists with novel ideas that could change the trajectory of a brain tumor diagnosis. In 2020, the ABTA has awarded nearly $400,000 towards 11 new research grants to foster innovation in the diagnosis and treatment of brain tumors in adults and children.
Learn more about the ABTA Research program and available grant opportunities.